125 research outputs found
Body mass index best predicts recovery of recombinant factor VIII in underweight to obese patients with severe haemophilia A
Background Factor VIII (FVIII) products are usually dosed according to body weight
(BW). This may lead to under- or over-dosing in underweight or obese patients,
respectively.
Objective This article evaluates the pharmacokinetics (PK) of recombinant FVIII
concentrate, particularly recovery, in relation to body mass index (BMI) and other
body composition descriptors.
Materials and Methods Thirty-five previously treated adults with severe haemophilia
A from five BMI categories (underweight, normal, overweight, obese class I and II/III)
were included. PK was evaluated after 50 IU per kilogram of BW single-dose recombinant
FVIII (turoctocog alfa). The body composition variable was based on measurements
of weight, height, bioimpedance analysis, and dual-energy X-ray
absorptiometry. A dosing model was derived to achieve similar peak FVIII activity
levels across BMI categories.
Results A statistically significant positive association between BMI and C30min,
IR30min, and AUC0–inf was observed; CL and Vss showed a significant negative association
with BMI; t½ was independent of BMI and other parameters. The dosing model
introduced a correction factor ‘M’ for each BMI category, based on linear regression
analysis of C30min against BMI, which ranged from 0.55 for underweight to 0.39 for
obese class II/III. This model achieved similar peak FVIII activity levels across BMI
categories, estimating an average dose adjustment of þ243.3 IU (underweight) to
–1,489.6 IU (obese class II/III) to achieve similar C30min.
Conclusion BMI appears to be the best predictor of recombinant FVIII recovery;
however, PK endpoints were also dependent on other body composition variables. The
model demonstrated that dosing can be adjusted for individual BMI to achieve better
FVIII predictability across BMI categoriesThis work was funded by Novo Nordisk A/S (Bagsværd, Denmark)
Intracerebral hemorrhage as a first sign of pheochromocytoma: case report and review of the literature
Pheochromocytomas and sympathetic paragangliomas are rare catecholamine-secreting tumours that represent very rare causes of intracerebral haemorrhage in the young, with only a few cases reported. A 32-year-old man presented to our emergency department because of sudden onset of severe headache. He had a six-month history of paroxysmal headache, palpitations, and sweating. During examination he became somnolent and developed left-sided hemiplegia. A computed tomographic (CT) scan of the brain showed a right temporoparietal haematoma. He was admitted to the Clinic for Neurosurgery and the haematoma was evacuated. The patient was comatose, on assisted respiration, with frequent hypertensive crises. An examination for possible secondary causes of hypertension was undertaken. Plasma metanephrine value was elevated (414 pg/mL, reference values < 90 pg/mL). Abdominal CT scans revealed a large mass (6 cm) in the right adrenal gland. After adequate control of the hypertension was achieved with nonselective alpha- and beta-adrenergic blockers the tumour was excised. The histopathologic findings confirmed the diagnosis of pheochromocytoma. The genetic analysis demonstrated a duplication in exon 1 of the VHL gene. We reported a rare, potentially fatal complication of pheochromocytoma — an intracerebral haemorrhage. This case and review of similar rare cases in the literature illustrate the importance of early recognition of the characteristic symptoms of catecholamine excess in young patients with hypertension
Opis przypadku — występujący rodzinnie wewnątrzczaszkowo germinoma
Background. Intracranial germinomas (ICG) are uncommon brain neoplasms with extremely rare familial occurance. Since ICG invades hypothalamus and/or pituitary, the endocrine dysfunction is one of the common determinants of these tumors.
We presented two brothers with the history of ICG. Patient 1 is a 25-year-old male who had been suffering from the weakness of the right half of his body at the age of 18. Cranial MRI revealed mass lesion in the left thalamus. He underwent neurosurgery, tumor was removed completely. Histopathological (HP) and immunohistochemical analyses verified the diagnosis of pure germinoma. He experienced complete remission of the tumor after a radiation therapy. At the age of 22 the diagnosis of isolated growth hormone deficiency (IGHD) was established and GH replacement was initiated. Patient 2 is a 20-year old boy who was presented with diabetes insipidus at the age of 12. MRI detected tumor in the third ventricle and pineal region. After the endoscopic tumor biopsy the HP diagnosis was pure germinoma. He received chemotherapy followed by radiotherapy, and treated with GH during childhood. At the age of 18 GH replacement was reintroduced. A six month follow-up during the next two years in both brothers demonstrated the IGF1 normalization with no MRI signs of tumor recurrence.
Conclusion. To the best of our knowledge so far, only six reports have been published related to familial ICG. The presented two brothers are the first report of familial ICG case outside of Japan. They are treated successfully with GH therapy in adult period.
Wstęp: Rozrodczaki wewnątrzczaszkowe (intracranial germinomas, ICG) to rzadkie nowotwory mózgu, a szczególnie rzadko stwierdza się ich występowanie rodzinne. W związku z tym, że ICG zajmuje podwzgórze i/lub przysadkę mózgową, zaburzenia endokrynologiczne są jednym z najczęstszych wyznaczników obecności tych guzów.
W pracy przedstawiono dwóch braci z ICG. Pacjent 1 to 25-letni mężczyzna, u którego w wieku 18 lat wystąpiło osłabienie mięśni po lewej stronie ciała. Badanie metodą rezonansu magnetycznego (MRI) czaszki ujawniło masę w lewym wzgórzu. Chorego poddano zabiegowi neurochirurgicznemu, podczas którego guz został całkowicie usunięty. Badania histopatologiczne i immunohistochemiczne potwierdziły rozpoznanie czystej postaci rozrodczaka. Po radioterapii nastąpiła całkowita remisja guza. W wieku 22 lat u chorego zdiagnozowano izolowany niedobór hormonu wzrostu (isolated growth hormone deficiency, IGHD) i wdrożono terapię zastępczą hormonem wzrostu (growth hormone, GH). Genetyczna analiza molekularna tkanki guza wykazała mutację w eksonie 2 w genie KRAS. Pacjent 2 to 20-letni mężczyzna, u którego w wieku 12 lat stwierdzono moczówkę prostą. W badaniu MRI wykryto guz w okolicy trzeciej komory i szyszynki. Po ocenie histopatologicznej materiału pobranego za pomocą biopsji endoskopowej postawiono diagnozę czystego rozrodczaka. U chorego zastosowano chemioterapię, a następnie radioterapię, a także podawano GH w okresie dzieciństwa. W wieku 18 lat u chorego wznowiono terapię GH. Sześciomiesięczna obserwacja obu braci w następnych 2 latach wykazała normalizację IGF1 przy braku objawów nawrotu guza w badaniu MRI.
Wnioski: Według najlepszej wiedzy autorów dotychczas opublikowano 6 doniesień na temat rodzinnego występowania ICG. Przedstawieni w niniejszej pracy bracia są pierwszym opisanym przypadkiem rodzinnego ICG poza Japonią. W okresie dorosłym chorzy są leczeni GH z dobrym skutkiem
Circulating aryl hydrocarbon receptor-interacting protein (AIP) is independent of GH secretion.
Background: Aryl hydrocarbon receptor-interacting protein (AIP) is evolutionarily conserved and expressed widely throughout the organism. Loss-of-function AIP mutations predispose to young-onset pituitary adenomas. AIP co-localizes with growth hormone in normal and tumorous somatotroph secretory vesicles. AIP protein is detectable in circulation. We aimed to investigate possible AIP and GH co-secretion, by studying serum AIP and GH levels at baseline and after GH stimulation or suppression, in GH deficiency (GHD) and in acromegaly patients. Subjects and methods: Insulin tolerance test (ITT) was performed in GHD patients (n = 13) and age-BMI-matched normal GH axis control patients (n = 31). Oral glucose tolerance test (OGTT) was performed in active acromegaly patients (n = 26) and age-BMI-matched normal GH axis control patients (n = 18). In-house immunometric assay was developed for measuring circulating AIP. Results: Serum AIP levels were in the 0.1 ng/mL range independently of gender, age or BMI. Baseline AIP did not differ between GHD and non-GHD or between acromegaly and patients with no acromegaly. There was no change in peak, trough or area under the curve during OGTT or ITT. Serum AIP did not correlate with GH during ITT or OGTT. Conclusions: Human circulating serum AIP in vivo was assessed by a novel immunometric assay. AIP levels were independent of age, sex or BMI and unaffected by hypoglycaemia or hyperglycaemia. Despite co-localization in secretory vesicles, AIP and GH did not correlate at baseline or during GH stimulation or suppression tests. A platform of reliable serum AIP measurement is established for further research of its circulatory source, role and impact.Serbian Ministry of Science (Project number 175033)MS from Society for Endocrinology (Practical Skills Grant)MS from Society for Endocrinology (Practical Skills Grant)British Society for Neuroendocrinology (Research Visit Grant)European Society of Endocrinology (Short Term Fellowship)Wellcome Clinical Training Fellowship (Grant no 097970/Z/11/Z)
A quick, simplified approach to the evaluation of combustion rate from an internal combustion engine indicator diagram
In this paper a simplified procedure of an internal combustion engine in-cylinder pressure record analysis has been presented The method is very easy for programming and provides quick evaluation of the gas temperature and the rate of combustion. It is based on the consideration proposed by Hohenberg and Killman, but enhances the approach by involving the rate of heat transferred to the walls that was omitted in the original approach. It enables the evaluation of the complete rate Of heat released by combustion (often designated as gross heat release rate or fuel chemical energy release rate), not only the rate of heat transferred to the gas (which is often designated as net heat release rate). The accuracy of the method has been also analyzed and it is shown that the errors caused by the simplifications in the model are very small, particularly if the crank angle step is also small A several practical applications on recorded pressure diagrams taken from both spark ignition and compression ignition engine are presented as well
Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia
The gastrointestinal “hunger” hormone ghrelin is the only known circulating peripheral molecule with the ability to decrease body fat utilization and to increase body weight gain. Accordingly, due to ghrelin’s effects to promote food intake while decreasing energy expenditure ghrelin may offer potential as a drug for treatment of eating/wasting disorders and cachexia. Therapeutic potential of ghrelin and ghrelin analogues to promote food intake and body weight gain was recently indicated in several clinical studies. The recent discovery of the ghrelin O-acyltransferase as the key enzyme responsible for ghrelin acylation has further deepened our understanding of ghrelin activation, thereby paving the way for more efficient targeting of the ghrelin pathway. Here, we summarize the current knowledge pertaining to the potential of the endogenous ghrelin system as a drug target for the treatment of eating/wasting disorders and cachexia
Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation-Positive Child
UK India Education Research Initiative and the British Council (75-2014; to P.D.)Council of Scientific and Industrial Research, University Grants Commission, for financial support (2061330632; to A.R.).Medical Research Council (MR/M018539/1; to M.K
Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors
Context
Germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene are responsible for a subset of familial isolated pituitary adenoma (FIPA) cases and sporadic pituitary neuroendocrine tumors (PitNETs).
Objective
To compare prospectively diagnosed AIP mutation-positive (AIPmut) PitNET patients with clinically presenting patients and to compare the clinical characteristics of AIPmut and AIPneg PitNET patients.
Design
12-year prospective, observational study.
Participants & Setting
We studied probands and family members of FIPA kindreds and sporadic patients with disease onset ≤18 years or macroadenomas with onset ≤30 years (n = 1477). This was a collaborative study conducted at referral centers for pituitary diseases.
Interventions & Outcome
AIP testing and clinical screening for pituitary disease. Comparison of characteristics of prospectively diagnosed (n = 22) vs clinically presenting AIPmut PitNET patients (n = 145), and AIPmut (n = 167) vs AIPneg PitNET patients (n = 1310).
Results
Prospectively diagnosed AIPmut PitNET patients had smaller lesions with less suprasellar extension or cavernous sinus invasion and required fewer treatments with fewer operations and no radiotherapy compared with clinically presenting cases; there were fewer cases with active disease and hypopituitarism at last follow-up. When comparing AIPmut and AIPneg cases, AIPmut patients were more often males, younger, more often had GH excess, pituitary apoplexy, suprasellar extension, and more patients required multimodal therapy, including radiotherapy. AIPmut patients (n = 136) with GH excess were taller than AIPneg counterparts (n = 650).
Conclusions
Prospectively diagnosed AIPmut patients show better outcomes than clinically presenting cases, demonstrating the benefits of genetic and clinical screening. AIP-related pituitary disease has a wide spectrum ranging from aggressively growing lesions to stable or indolent disease course
Cures Like a Charm: Acupuncture and Its Integration Into Modern Medicine
Acupuncture is among the oldest healing practices in the world. As part of traditional Chinese medicine (TCM), acupuncture aims to restore and maintain health through the stimulation of specific points on the body. In the United States, where practitioners incorporate healing traditions from China, Japan, Korea, and other countries, acupuncture is considered part of complementary and alternative medicine (CAM). This paper discusses Acupuncture and how the modern medical field has integrated it into its field. This paper also argues that Acupuncture has risen above all other alternative medicines because of its incredible healing ability, minimum side effects, and cost-effectiveness
Audio guidance for optimal placement of an auditory brainstem implant with magnetic navigation and maximum clinical application accuracy
Presented at the 25th International Conference on Auditory Display (ICAD 2019) 23-27 June 2019, Northumbria University, Newcastle upon Tyne, UK.For patients with ineffective auditory nerve and complete hearing loss, Auditory Brainstem Implant (ABI) presents diversity of hearing sensations to help with sound consciousness and communication. At present, during the surgical intervention, surgeons use preoperative patient images to determine optimal position of an ABI on cochlear nucleus on brainstem. When found, the optimal position is marked and mentally mapped by the surgeon; Next, the surgeon tries to locate the optimal position in patientメs head again and places the ABI. The aim of this project is to provide the surgeon with maximum clinical application accuracy guidance to store the optimal position for the implant, and to provide intuitive audio guidance for positioning the implant at the stored optimal position. By using three audio methods, in combination with visual information on Image-Guided Surgery (IGS), surgeon should spend less time looking at the screen, and more time focused on the patient
- …